SecBot SecBot
SECBOTREPLAY Home › Report › LFCR

LFCR · Lifecore Biomedical disclosed that holders of all 49,263 outstanding…

LIFECORE BIOMEDICAL, INC. \DE\ · 8-K filed Jul 2, 2026 at 17:17 ET

At the news

BEARISHIMPACT 7/10

8-K filed Jul 2, 2026 at 17:17 ET

Lifecore Biomedical disclosed that holders of all 49,263 outstanding Series A Redeemable Convertible Preferred shares have submitted redemption notices, requiring approximately $52.1 million in cash by December 28, 2026. The company's current liquidity of $38.1 million ($20.8M cash + $17.3M revolver) falls short of this obligation, and lender consent is needed to proceed. Management is evaluating strategic alternatives including debt/equity financing or asset sales to fund the redemption, creating near-term uncertainty and dilution risk for common shareholders.

  • Holders of all 49,263 shares of Series A Redeemable Convertible Preferred Stock submitted redemption notices between June 29-30, 2026
  • Redemption price is $1,000 per share plus accrued dividends; total required amount ~$52.1 million due December 28, 2026
  • Accrued and unpaid dividends of $0.9 million as of June 30, 2026; total liquidation value ~$50.2 million
  • The company had $38.1 million in total liquidity as of March 31, 2026 ($20.8M cash + $17.3M revolver availability)

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access